5.9.2019 To marketing authorisation holders: The process for notifying shortages will change gradually starting from 1 October 2019

30.8.2019 For marketing authorisation holders: the naming of certain liposomal medicinal products must be further specified by 30 September

26.8.2019 Meds75+ database shortlisted as the medication safety influencer of the year

23.7.2019 EU pharmaceutical industry operators seek closer cooperation

19.7.2019 The EU and the USA reach a milestone on the mutual recognition of GMP inspections of pharmaceutical manufacturers

4.7.2019 Fimea to host a number of pharmaceutical meetings during Finland's Presidency

1.7.2019 Fimea issued Fysioline Oy with a marketing ban decision concerning the use of starter packs of the Trampalgin medicinal product in marketing

27.6.2019 Cannabidiol (CBD) is controlled as a medicine in Finland

26.6.2019 Fimea welcomes requests to act as RMS

11.6.2019 Meds75+ database now available for use as open data